GLAXOSMITHKLINE PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,943 INR | -0.28% |
|
+2.09% | +2.38% |
| Mar. 22 | GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities | CI |
| Feb. 29 | Cynata Therapeutics Names Chief Business Officer; Shares Plunge 14% | MT |
Evolution of the average Target Price on GlaxoSmithKline Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
e6ced66bab5597b04.sNUwcoyaBtgzmG8A5RABFNbQNdxOWU_gK3zF2s6MgaU.g7JbFbjAMrZwzCFq0mFpQo6SQe9jawyTSCWxnuPV8Mad7Vkqvf5lgXfxJg~a71ec5edef4ca9fef1e9b0d66c47c60e
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
1,943
INR
Average target price
2,141
INR
Spread / Average Target
+10.22%
High Price Target
2,450
INR
Spread / Highest target
+26.12%
Low Price Target
1,895
INR
Spread / Lowest Target
-2.45%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- GLAXO Stock
- Consensus GlaxoSmithKline Pharmaceuticals Limited
